Original Research
Published on 11 Aug 2022
Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
in Experimental Pharmacology and Drug Discovery
- 5,743 views
- 17 citations










